A COST-MINIMIZATION ANALYSIS OF NON-STEROIDAL ANALGESICS
Author(s)
Gankhulug B1, Dorj G2, Dorj G1, Gendenragchaa B3, Sanjjav T3, Tsolmon N3, Byambaa G3, Sunderland B2
1Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia, 2Curtin University of Technology, Perth, Australia, 3ISPOR Chapter Mongolia, Ulaanbaatar, Mongolia
OBJECTIVES: Neurological disorders represent a high financial burden to healthcare providers. This study seeks to estimate and compare the costs of treating patients hospitalized with neurological disorder, with oral and extravascular non-steroidal anti-inflammatory agents, thus determining which treatment is cost minimizing. METHODS: A cost-minimization analysis is a commonly applied pharmacoeconomic method considering that two or more treatment alternatives are therapeutically equivalent. It was undertaken retrospectively for patients diagnosed and received oral and extravascular non-steroidal analgesics= agents. Data were collected from three urban and one rural hospital of Mongolia. The analysis considered the cost to the health service and Tree Age® software was employed to analyze the decision model and detect the statistical differences. RESULTS: The study recruited a total of 398 adult patients with a neurological disorder and admitted to the selected tertiary level hospitals. Patients diagnosed with neurological disorder were mainly aged between 66-80 years old and female (n=236, 70%). Most patients were administered an intramuscular non-steroidal anti-inflammatory agents (n=278, 90.8%). Intramuscular diclofenac treatment was found to be more expensive than oral treatment (tugrug 12397.5 versus tugrug 1235; difference tugrug 11702.5), such that treatment of neurological disorder with oral diclofenac would result in savings of between tugrug 7637.5 and tugrug 11702.5 per patient admitted (р=.00021). CONCLUSIONS: The findings demonstrate that a switch down therapy of injectable diclofenac sodium for the period of first three days of hospitalization to oral form for the remaining days is a cost-effective alternative for the majority of patients with neurological disorder admitted to hospitals in Mongolia.
Conference/Value in Health Info
2018-09, ISPOR Asia Pacific 2018, Tokyo, Japan
Value in Health, Vol. 21, S2 (September 2018)
Code
PND17
Topic
Economic Evaluation, Health Service Delivery & Process of Care
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Prescribing Behavior
Disease
Neurological Disorders